Upgrade to SI Premium - Free Trial

Immuneering Corporation (IMRX) PT Lowered to $12; Piper Sandler: 'We Remain Buyers'

March 9, 2026 8:05 AM
Piper Sandler analyst Allison M. Bratzel lowered the price target on Immuneering Corporation (NASDAQ: IMRX) to $12.00 (from $13.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change